PB

Peter Baricev

Corporate Development at Pinnacle Clinical Research

Peter Baricev has a diverse work experience that spans multiple industries. From 2015 to 2017, they worked at Gerber/Taylor Management Co., focusing on alternative investments. In 2017, they joined International Paper's Global Financial Services (GFS) Group. Moving into the private equity sector, Peter worked as a Private Equity Analyst at Five Points Capital from 2018 to 2020. Following that, they served as a Private Equity Associate at Graham Healthcare Capital from 2020 to 2021. Currently, Peter is an Associate at LongueVue Capital, starting in 2022. Additionally, they recently joined Pinnacle Clinical Research in 2022, specializing in corporate development for Phase I-IV trial research services, particularly in the NASH/NAFLD therapeutic area.

Peter Baricev has a Bachelor of Arts - BA degree in Commerce and Business with a concentration in Finance and International Business from Rhodes College. Peter also studied International Business at the University of Antwerp. Additionally, they attended St Pauls School, although no specific degree or field of study was mentioned for this institution.

Links

Timeline

  • Corporate Development

    October, 2022 - present

A panel showing how The Org can help with contacting the right person.